Key facts
- This page summarizes Spencer R. Berthelsen's Form 4 filing for IONIS PHARMACEUTICALS INC (IONS).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 17 Jul 2024, 17:02.
Spencer R. Berthelsen - 15 Jul 2024 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)
- Reporting relationship
- Director
- Issuer ticker
- IONS
- Reported as of
- 15 Jul 2024
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Jul 2024, 17:02:26 UTC
- Prior SEC filing
- 03 Jul 2024
- Next SEC filing
- 02 Jul 2025
- Source filing
- View source filing
- Reporting owner signature
- By: Patrick R. O'Neil, attorney-in-fact For: Spencer R. Berthelsen
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Spencer R. Berthelsen filed Form 4 for IONIS PHARMACEUTICALS INC (IONS) on 17 Jul 2024.
Change
- Previous filing in this sequence was filed on 03 Jul 2024.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
IONS
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +4,677
- Change %
- +3.2%
- Price
- $0.000000
- Shares after
- 151,934
- Date
- 15 Jul 2024
- Ownership
- Direct
- Footnotes
- F1
IONS
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 70
- Date
- 15 Jul 2024
- Ownership
- by Daughter
- Footnotes
- F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
IONS
transaction
Derivative
Restricted Stock Unit
Options Exercise
- Transaction value
- $0
- Shares
- -4,677
- Change %
- -53%
- Price
- $0.000000
- Shares after
- 4,079
- Date
- 15 Jul 2024
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 4,677
- Exercise price
- $0.000000
- Footnotes
- F3, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Acquired pursuant to vesting and release of shares in accordance with a Restricted Stock Unit award.
Footnote F2
The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
Footnote F3
Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
Footnote F4
Restricted Stock Units vest 100% on either the first anniversary of the date of grant or the next regularly scheduled annual meeting of stockholders of the Company, whichever occurs earlier, and are delivered to the reporting person on the July 15th following the vesting date. Upon vesting, the Restricted Stock Units will be paid in whole shares of Ionis common stock or cash as may be determined by the Company.